Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Purchased by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 18.2% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 27,268 shares of the company's stock after buying an additional 4,199 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank's holdings in Ryan Specialty were worth $1,750,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Sanctuary Advisors LLC lifted its position in Ryan Specialty by 1.2% during the fourth quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company's stock worth $1,045,000 after buying an additional 188 shares in the last quarter. State of Alaska Department of Revenue lifted its position in Ryan Specialty by 1.6% during the fourth quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company's stock worth $778,000 after buying an additional 190 shares in the last quarter. CIBC Asset Management Inc raised its position in Ryan Specialty by 5.6% in the fourth quarter. CIBC Asset Management Inc now owns 3,674 shares of the company's stock valued at $236,000 after purchasing an additional 196 shares during the period. Loomis Sayles & Co. L P raised its position in Ryan Specialty by 26.3% in the third quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company's stock valued at $91,000 after purchasing an additional 286 shares during the period. Finally, Exchange Traded Concepts LLC raised its position in Ryan Specialty by 2.6% in the fourth quarter. Exchange Traded Concepts LLC now owns 11,760 shares of the company's stock valued at $755,000 after purchasing an additional 295 shares during the period. Hedge funds and other institutional investors own 84.82% of the company's stock.

Remove Ads

Insider Buying and Selling at Ryan Specialty

In related news, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Nicholas Dominic Cortezi sold 29,466 shares of the firm's stock in a transaction dated Monday, January 13th. The stock was sold at an average price of $65.06, for a total transaction of $1,917,057.96. Following the completion of the transaction, the director now directly owns 45,409 shares in the company, valued at $2,954,309.54. This represents a 39.35 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 241,360 shares of company stock worth $16,006,428. 11.10% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

RYAN has been the topic of a number of research analyst reports. Wells Fargo & Company lifted their target price on Ryan Specialty from $64.00 to $69.00 and gave the company an "equal weight" rating in a research report on Friday, February 21st. Royal Bank of Canada dropped their price objective on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a research note on Friday, February 21st. UBS Group lifted their price objective on Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. Morgan Stanley assumed coverage on Ryan Specialty in a research note on Thursday, December 5th. They issued an "overweight" rating and a $90.00 price objective for the company. Finally, Barclays lifted their price objective on Ryan Specialty from $76.00 to $88.00 and gave the company an "overweight" rating in a research note on Thursday, November 21st. One analyst has rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $75.27.

Ryan Specialty Stock Down 0.8 %

RYAN traded down $0.56 on Friday, hitting $71.13. 1,090,391 shares of the company were exchanged, compared to its average volume of 908,150. Ryan Specialty Holdings, Inc. has a twelve month low of $48.48 and a twelve month high of $75.97. The company has a market cap of $18.63 billion, a price-to-earnings ratio of 103.09, a price-to-earnings-growth ratio of 1.19 and a beta of 0.71. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The firm has a 50-day moving average price of $67.94 and a two-hundred day moving average price of $67.91.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.02). The firm had revenue of $663.53 million during the quarter, compared to analysts' expectations of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. On average, equities analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date of this dividend was Tuesday, March 4th. This is a boost from Ryan Specialty's previous quarterly dividend of $0.11. Ryan Specialty's dividend payout ratio is 69.57%.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.